Filing Details
- Accession Number:
- 0001093557-11-000040
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-09-19 21:18:08
- Reporting Period:
- 2011-09-15
- Filing Date:
- 2011-09-19
- Accepted Time:
- 2011-09-19 21:18:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1520386 | Martin Doordan | 6340 Sequence Drive San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-09-15 | 2,000 | $12.35 | 23,641 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The number of securities beneficially owned by Mr. Doordan include 1,967 restricted share units and 19,674 restricted share units. Additional information on the restricted share units is provided below.On May 26, 2011, the Date of Grant, Mr. Doordan received 1,967 restricted share units- RSUs. The RSUs are restricted and will vest in full on the one year anniversary of the Date of Grant, or May 26, 2012. The RSUs represent a contingent right to receive one share of DexCom, Inc. common stock. As of the date of this filing, no RSUs have vested.On May 26, 2011, the Date of Grant, Mr. Doordan received 19,674 restricted share units-RSUs. The RSUs are restricted and subject to vesting in three equal annual installments from the Date of Grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock. As of the date of this filing, no RSUs have vested.